Skip to content

Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse

Integrated CBT for Substance Use and Depressive Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00108407
Enrollment
Unknown
Registered
2005-04-15
Start date
2004-10-31
Completion date
Unknown
Last updated
2009-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Abuse, Cannabis Abuse, Major Depressive Disorder, Substance-Related Disorders

Keywords

Alcohol Abuse/Dependence, Alcohol Use Disorders, Cannabis Abuse/Dependence, Depression, Dual diagnosis, Dysthymia, Stimulant Abuse/Dependence, Substance Use Disorders

Brief summary

The purpose of this study is to determine whether Integrated Cognitive Behavioral Therapy or Twelve Step Facilitation Therapy is most effective for treatment of dually diagnosed veterans with depressive and substance use disorders.

Detailed description

Depression is the most frequent co-occuring mental health disorder among adults with substance use disorders, and such comorbidity is often associated with poorer treatment outcomes. Although there is an urgent need for effective treatments specific for dual-diagnosis adults, few studies have been conducted to address this need. Comparison: This study will compare substance use and depression symptoms of individuals in two different psychotherapy groups: Integrated Cognitive Behavioral Therapy and Twelve Step Facilitation Therapy. Symptoms and substance use will be compared during the active treatment phase (24 weeks) and for one year following the end of the active treatment.

Interventions

BEHAVIORALTwelve Step Facilitation Therapy

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Individuals diagnosed with one or more substance use disorders (alcohol, cannabis, and or stimulant abuse/dependence) and an independent co-occurring depressive disorder (major depression or dysthymia) will be included.

Exclusion criteria

* Individuals with substance induced mood disorders and individuals experiencing persistent psychotic symptoms. * Those with life threatening or unstable medical illness, neurological disorders, or inability to read will be excluded. * Individuals currently prescribed steroids, disulfiram, or long acting benzodiazepines will be excluded.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026